These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37374379)

  • 21. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney Tubulointerstitial Fibrosis and Tubular Secretion.
    Garimella PS; Katz R; Waikar SS; Srivastava A; Schmidt I; Hoofnagle A; Palsson R; Rennke HG; Stillman IE; Wang K; Kestenbaum BR; Ix JH
    Am J Kidney Dis; 2022 May; 79(5):709-716. PubMed ID: 34571064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China.
    Zhu X; Xiong X; Yuan S; Xiao L; Fu X; Yang Y; Tang C; He L; Liu F; Sun L
    J Diabetes Complications; 2016 Apr; 30(3):537-41. PubMed ID: 26796433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary MicroRNA-21-5p as Potential Biomarker of Interstitial Fibrosis and Tubular Atrophy (IFTA) in Kidney Transplant Recipients.
    Gniewkiewicz MS; Paszkowska I; Gozdowska J; Czerwinska K; Sadowska-Jakubowicz A; Deborska-Materkowska D; Perkowska-Ptasinska A; Kosieradzki M; Durlik M
    Diagnostics (Basel); 2020 Feb; 10(2):. PubMed ID: 32092939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.
    Racca MA; Novoa PA; Rodríguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC
    Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
    García-Carro C; Dörje C; Åsberg A; Midtvedt K; Scott H; Reinholt FP; Holdaas H; Seron D; Reisæter AV
    Transplantation; 2017 Jun; 101(6):1410-1415. PubMed ID: 27163535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
    Wang Y; Wang YP; Tay YC; Harris DC
    Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine Angiotensin II Signature Proteins as Markers of Fibrosis in Kidney Transplant Recipients.
    Mohammed-Ali Z; Tokar T; Batruch I; Reid S; Tavares-Brum A; Yip P; Cardinal H; Hébert MJ; Li Y; Kim SJ; Jurisica I; John R; Konvalinka A
    Transplantation; 2019 Jun; 103(6):e146-e158. PubMed ID: 30801542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy.
    Furic-Cunko V; Kes P; Coric M; Hudolin T; Kastelan Z; Basic-Jukic N
    Int Urol Nephrol; 2015 Jul; 47(7):1219-29. PubMed ID: 25962604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):245-50. PubMed ID: 24626060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection.
    Kummer JA; Wever PC; Kamp AM; ten Berge IJ; Hack CE; Weening JJ
    Kidney Int; 1995 Jan; 47(1):70-7. PubMed ID: 7731173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased urinary cystatin C level is associated with interstitial fibrosis and tubular atrophy in kidney allograft recipients.
    Mendes Mde F; Salgado JV; de Ribamar Lima J; Ferreira TC; Silva GE; Filho NS
    Clin Biochem; 2015 May; 48(7-8):546-9. PubMed ID: 25746149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.
    Ho J; Rush DN; Gibson IW; Karpinski M; Storsley L; Bestland J; Stefura W; HayGlass KT; Nickerson PW
    Transplantation; 2010 Aug; 90(4):394-400. PubMed ID: 20625355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies.
    Leatherwood C; Speyer CB; Feldman CH; D'Silva K; Gómez-Puerta JA; Hoover PJ; Waikar SS; McMahon GM; Rennke HG; Costenbader KH
    Semin Arthritis Rheum; 2019 Dec; 49(3):396-404. PubMed ID: 31277928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
    Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.
    Nogare AL; Veronese FV; Carpio VN; Montenegro RM; Pedroso JA; Pegas KL; Gonçalves LF; Manfro RC
    BMC Nephrol; 2015 Feb; 16():19. PubMed ID: 25884518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of anti-vimentin antibodies in renal transplantation.
    Besarani D; Cerundolo L; Smith JD; Procter J; Barnardo MC; Roberts IS; Friend PJ; Rose ML; Fuggle SV
    Transplantation; 2014 Jul; 98(1):72-8. PubMed ID: 24978037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy.
    Mengel M; Bock O; Priess M; Haller H; Kreipe H; Gwinner W
    Clin Nephrol; 2008 Jun; 69(6):408-16. PubMed ID: 18538116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.